Human Research Protection Program
Administered through the TTUHSC Research Integrity office, TTUHSC IRBs review research involving human subjects. All human research studies are reviewed by the IRB before they begin and throughout the project to evaluate risks to subjects and compliance with federal regulations and institutional policies.
TTUHSC has a Federal-Wide Assurance (FWA) # 00006767 with the Department of Health and Human Services to protect the rights and welfare of participants involved in research affiliated with this institution.
Two TTUHSC IRBs serve three campuses. For contact information, board membership, and submission deadlines select your campus below.
There is a new process in place by which research projects conducted at UMC by TTUHSC faculty are being approved. For your reference, the Flow Sheet found here delineates the process. Should you have any additional questions or concerns, please contact:
TTUHSC faculty conducting minimal risk research at Covenant Medical Center/Covenant Children's, or using their medical records should utilize the process described here for single IRB review of the project. Note that the TTUHSC IRB will not be able to provide final approval of the project until all St. Joseph Health requirements have been met.
When TTUHSC researchers conduct research at other institutions, TTUHSC must enter into a formal written agreement with the other institution to define the responsibilities of each entity. No research may begin until an agreement has been formally executed and the designated IRB has approved the project.
The following institutions have established agreements with TTUHSC that allow the TTUHSC Amarillo IRB to review and provide continuing oversight of human research conducted by TTUHSC faculty. These agreements define the parameters for TTUHSC IRB review, including the conditions under which the review will be considered, each institution's responsibilities and financial commitments.
Institutions for which the TTUHSC IRB is the IRB of record may reserve the regulatory right (FDA 21 CFR 56.12, DHHS 45 CFR 46.112) to exercise institutional disapproval of research the Board has approved, but may not approve research that has been disapproved by a TTUHSC IRB serving as the IRB of record.